GlassScriptPhysician profile
Omar A Abu Anza
NPI 1629465802
$2,481.51
in general payments reported to CMS, 2019-2025
9 companies · $1,999 in 2025
The $1,999 reported for 2025 was more than what 85% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.46 · 2023: $400 · 2024: $58.29 · 2025: $1,999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164 · Travel and Lodging: $1,110 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.45 |
| Travel and Lodging | $1,109.90 |
| Education | $182.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,802.70 | 2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder |
| B. Braun Interventional Systems INC. | $294.79 | 2023 | |
| Abbott Laboratories | $111.30 | 2025 | Amplatzer Piccolo |
| Medtronic, INC. | $67.97 | 2023 | Harmony |
| Irhythm Technologies, INC. | $61.49 | 2022-2023 | Zio Xt Patch |
| Edwards Lifesciences Corporation | $53.14 | 2025 | The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Boston Scientific Corporation | $44.77 | 2024 | |
| Philips North America LLC | $31.83 | 2025 | Ecc Solutions |
| Ani Pharmaceuticals, INC. | $13.52 | 2024 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Abu Anza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.